EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review

Bradley J Monk, Domenica Lorusso, Keiichi Fujiwara, Jalid Sehouli

Cancer Treatment Reviews · 2025-06 · 137 · 102945

DOI: 10.1016/j.ctrv.2025.102945 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2025-06. Verfasst von Bradley J Monk und 3 weiteren Autor:innen. Beteiligte Einrichtung: GOG Foundation, Philadelphia, PA, USA; Division of Gynecologic Oncology, Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA.…. Hauptthemen laut MEDLINE: Bevacizumab, Ovarian Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Antineoplastic Agents, Immunological. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Merck Sharp & Dohme UK Ltd, AstraZeneca PLC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BevacizumabOvarian NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic Agents, ImmunologicalHumansFemaleNeoplasm StagingProgression-Free Survival

Stichwörter der Autor:innen

Anti-angiogenic therapyBevacizumabBiological therapyOlaparibOvarian cancerPARP inhibitor

Substanzen

BevacizumabAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • GOG Foundation, Philadelphia, PA, USA; Division of Gynecologic Oncology, Florida Cancer Specialists and Research Institute, West Palm Beach, FL, USA. Electronic address: bmonk@gog.org.
  • Gynecologic Oncology Unit, Humanitas San Pio X, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Department of Gynecology with Center for Oncological Surgery, Charité-Universitätsmedizin Berlin, Berlin, and North-Eastern German Society of Gynecological Oncology (NOGGO) - Arbeitsgemeinschaft Gynäkologische Onkologie…

Förderung

  • Merck Sharp & Dohme UK Ltd
  • AstraZeneca PLC

Zitieren

APA

Monk, B. J., Lorusso, D., Fujiwara, K., & Sehouli, J. (2025). Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review. Cancer Treatment Reviews, 137, 102945. https://doi.org/10.1016/j.ctrv.2025.102945

Vancouver

Monk BJ, Lorusso D, Fujiwara K, Sehouli J. Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review. Cancer Treatment Reviews. 2025;137:102945. doi:10.1016/j.ctrv.2025.102945

BibTeX
@article{Monk2025,
  author = {Monk, Bradley J and Lorusso, Domenica and Fujiwara, Keiichi and Sehouli, Jalid},
  title = {Optimal bevacizumab treatment strategy in advanced ovarian cancer: A review},
  journal = {Cancer Treatment Reviews},
  year = {2025},
  volume = {137},
  pages = {102945},
  doi = {10.1016/j.ctrv.2025.102945}
}
Kostenlos starten →